Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence

Purpose: To improve neuroendocrine neoplasm (NEN) management, the European Neuroendocrine Tumor Society (ENETS) recognised 62 Centers of Excellence (CoE). This retrospective study compares conformity of patients’ initial management within vs outside an ENETS CoE with clinical practice guidelines (CP...

Full description

Bibliographic Details
Main Authors: Carole Morin, Keo-Morakort Benedetto, Agathe Deville, Laurent Milot, Aurélie Theillaumas, Valérie Hervieu, Mathieu Pioche, Gilles Poncet, Julien Forestier, Laurent François, Francoise Borson-Chazot, Mustapha Adham, Catherine Lombard-Bohas, Thomas Walter
Format: Article
Language:English
Published: Bioscientifica 2022-06-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/11/6/EC-22-0097.xml
_version_ 1811332483951624192
author Carole Morin
Keo-Morakort Benedetto
Agathe Deville
Laurent Milot
Aurélie Theillaumas
Valérie Hervieu
Mathieu Pioche
Gilles Poncet
Julien Forestier
Laurent François
Francoise Borson-Chazot
Mustapha Adham
Catherine Lombard-Bohas
Thomas Walter
author_facet Carole Morin
Keo-Morakort Benedetto
Agathe Deville
Laurent Milot
Aurélie Theillaumas
Valérie Hervieu
Mathieu Pioche
Gilles Poncet
Julien Forestier
Laurent François
Francoise Borson-Chazot
Mustapha Adham
Catherine Lombard-Bohas
Thomas Walter
author_sort Carole Morin
collection DOAJ
description Purpose: To improve neuroendocrine neoplasm (NEN) management, the European Neuroendocrine Tumor Society (ENETS) recognised 62 Centers of Excellence (CoE). This retrospective study compares conformity of patients’ initial management within vs outside an ENETS CoE with clinical practice guidelines (CPGs). Methods: Patients diagnosed with a NEN between August 2018 and July 2020 and presented in the Lyon-CoE Multidisciplinary Tumour Board (MDT) were included. Factors potentially associated with the conformity of initial management (work-up and first treatment) to CPG underwent univariate and multivariate analyses. Results: Among the 615 included patients, 170 (27.6%) were initially managed in the CoE and 445 (72.4%) were only presented at the CoE-MDT. Patients in the CoE group more often had intestinal or pancreatic primaries, metastatic disease (61.8% vs 33%), hereditary syndrome, and a functioning tumour. Work-up conformity was 37.1% in the CoE (vs 29.9%, P = 0.09); this was 95.8% for the first treatment (vs 88.7%, P = 0.01). After multivariate analysis, CPG conformity was significantly higher for patients managed in the CoE, for younger patients, for those having a grade 1–2 tumour, and a genetic syndrome. Pancreatic and small intestinal (SI) NET surgeries performed in the CoE had a higher splenic preservation rate during left pancreatectomy, better detection of multiple tumours in SI surgeries, and higher number of resected lymph nodes. Conclusions: Given the widespread observance of CPG, not all patients require management in the CoE. Referral should be considered for more complex cases such as metastatic diseases, G2 tumours, or carcinoid syndromes. Finally, we should encourage the centralization of NET surgery.
first_indexed 2024-04-13T16:37:39Z
format Article
id doaj.art-f1cee055f6674d02bee186721fd5a5ed
institution Directory Open Access Journal
issn 2049-3614
language English
last_indexed 2024-04-13T16:37:39Z
publishDate 2022-06-01
publisher Bioscientifica
record_format Article
series Endocrine Connections
spelling doaj.art-f1cee055f6674d02bee186721fd5a5ed2022-12-22T02:39:23ZengBioscientificaEndocrine Connections2049-36142022-06-01116112https://doi.org/10.1530/EC-22-0097Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellenceCarole Morin0Keo-Morakort Benedetto1Agathe Deville2Laurent Milot3Aurélie Theillaumas4Valérie Hervieu5Mathieu Pioche6Gilles Poncet7Julien Forestier8Laurent François9Francoise Borson-Chazot10Mustapha Adham11Catherine Lombard-Bohas12Thomas Walter13Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, FranceHospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, FranceHospices Civils de Lyon, Hôpital Louis Pradel, Médecine Nucléaire, Bron, France; Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, FranceHospices Civils de Lyon, Hôpital Edouard Herriot, Radiologie, Lyon Cedex 03, France; University of Lyon, Université Lyon 1, FranceHospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, FranceCentre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France; University of Lyon, Université Lyon 1, France; Hospices Civils de Lyon, Institut de Pathologie Est, Bron Cedex, France University of Lyon, Université Lyon 1, France; Hospices Civils de Lyon, Hôpital Edouard Herriot, Gastroentérologie, Lyon Cedex 03, FranceCentre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France; University of Lyon, Université Lyon 1, France; Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, FranceHospices Civils de Lyon, Hôpital Louis Pradel, Exploration Fonctionnelle, Bron Cedex, FranceUniversity of Lyon, Université Lyon 1, France; Hospices Civils de Lyon, Hôpital Louis Pradel, Endocrinologie, Bron Cedex, FranceUniversity of Lyon, Université Lyon 1, France; Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, FranceHospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, FranceHospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France; Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France; University of Lyon, Université Lyon 1, France Purpose: To improve neuroendocrine neoplasm (NEN) management, the European Neuroendocrine Tumor Society (ENETS) recognised 62 Centers of Excellence (CoE). This retrospective study compares conformity of patients’ initial management within vs outside an ENETS CoE with clinical practice guidelines (CPGs). Methods: Patients diagnosed with a NEN between August 2018 and July 2020 and presented in the Lyon-CoE Multidisciplinary Tumour Board (MDT) were included. Factors potentially associated with the conformity of initial management (work-up and first treatment) to CPG underwent univariate and multivariate analyses. Results: Among the 615 included patients, 170 (27.6%) were initially managed in the CoE and 445 (72.4%) were only presented at the CoE-MDT. Patients in the CoE group more often had intestinal or pancreatic primaries, metastatic disease (61.8% vs 33%), hereditary syndrome, and a functioning tumour. Work-up conformity was 37.1% in the CoE (vs 29.9%, P = 0.09); this was 95.8% for the first treatment (vs 88.7%, P = 0.01). After multivariate analysis, CPG conformity was significantly higher for patients managed in the CoE, for younger patients, for those having a grade 1–2 tumour, and a genetic syndrome. Pancreatic and small intestinal (SI) NET surgeries performed in the CoE had a higher splenic preservation rate during left pancreatectomy, better detection of multiple tumours in SI surgeries, and higher number of resected lymph nodes. Conclusions: Given the widespread observance of CPG, not all patients require management in the CoE. Referral should be considered for more complex cases such as metastatic diseases, G2 tumours, or carcinoid syndromes. Finally, we should encourage the centralization of NET surgery.https://ec.bioscientifica.com/view/journals/ec/11/6/EC-22-0097.xmlneuroendocrine neoplasmenets center of excellencediagnostic managementconformity to clinical guidelines
spellingShingle Carole Morin
Keo-Morakort Benedetto
Agathe Deville
Laurent Milot
Aurélie Theillaumas
Valérie Hervieu
Mathieu Pioche
Gilles Poncet
Julien Forestier
Laurent François
Francoise Borson-Chazot
Mustapha Adham
Catherine Lombard-Bohas
Thomas Walter
Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence
Endocrine Connections
neuroendocrine neoplasm
enets center of excellence
diagnostic management
conformity to clinical guidelines
title Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence
title_full Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence
title_fullStr Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence
title_full_unstemmed Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence
title_short Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence
title_sort management of neuroendocrine neoplasms conformity with guidelines in and outside a center of excellence
topic neuroendocrine neoplasm
enets center of excellence
diagnostic management
conformity to clinical guidelines
url https://ec.bioscientifica.com/view/journals/ec/11/6/EC-22-0097.xml
work_keys_str_mv AT carolemorin managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT keomorakortbenedetto managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT agathedeville managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT laurentmilot managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT aurelietheillaumas managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT valeriehervieu managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT mathieupioche managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT gillesponcet managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT julienforestier managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT laurentfrancois managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT francoiseborsonchazot managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT mustaphaadham managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT catherinelombardbohas managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence
AT thomaswalter managementofneuroendocrineneoplasmsconformitywithguidelinesinandoutsideacenterofexcellence